Older Person's Exercise and Nutrition Study (OPEN)

April 25, 2019 updated by: Anne-Marie Bostrom, Karolinska Institutet

Older Person's Exercise and Nutrition Study (OPEN): a Simple Physical Exercise Combined With Protein Supplement - Effects on Functional Status and Independence Among Older People: A Cluster Randomised Controlled Trial

The novelty with the OPEN study is to evaluate the effects of the simple sit-to-stand exercise during routine care, in combination with an oral protein-rich supplement, on functional status and independence in frail older persons. In this study we will also explore the experiences among older persons in the intervention group as wells as among staff of promoting the sit-to-stand exercise and nutritional supplement to gain knowledge for implementation as a daily routine in nursing homes across Sweden.

Hypothesis The main hypothesis of the OPEN study is that physical exercise performed as a daily routine along with an oral protein-rich supplement, will result in improved functional status and independence in everyday life activities and thereby enhance health-related quality of life in older persons living in nursing homes. The primary outcome measure for functional status will be the number of sit-to-stands that the participant is able to complete in 30 seconds.

Specific aims Aim I: To study the effects of the sit-to-stand exercise combined with an oral protein-rich supplement on functional and nutritional status, and health-related quality of life, and the frequency and incidence of falls, pressure ulcers and incontinence in older persons living in nursing homes. Furthermore, the cost effectiveness of the combination of the sit to stand exercise and oral protein-rich supplement vs. the control group will also be examined.

Aim II: To describe the older persons' perceptions of daily being offered to conduct the sit-to-stand exercise and to drink the nutritional supplement.

Aim III: To describe staff's perceptions of supporting the sit-to-stand exercise and the nutritional supplement with older persons living in nursing homes.

Study Overview

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Stockholm, Sweden
        • Stockholms sjukhem

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

75 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Able to rise independently from a seated position to standing-

Exclusion Criteria:

  • BMI >30
  • severe dysphagia,
  • tube feeding,
  • severe kidney failure,
  • bedridden people,
  • terminal stage of life
  • Lack of informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Standard care
Experimental: Intervention

The participants will be supported to perform the sit-to-stand exercise at least four times per day during 12 weeks (7 days/week).

The participants will also be offered an oral protein-rich supplement (125 ml, 18 g protein (24% of RDI), 300 kcal) twice a day in conjunction with two of the four sit-to-stand exercises during 12 weeks (7 days/week).

The older person will be offered an oral protein-rich supplement (125 ml, 18 g protein (24% of RDI), 300 kcal) twice a day in conjunction with two of the four sit-to-stand exercises during 12 weeks (7 days/week).
The older person will get up from a chair to stand and then sit down again repeatedly at least four times per day, 7 days during 12 weeks
Other Names:
  • Sit-to-stand

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The primary outcome measure for functional status will be the number of sit-to-stands that the participant is able to complete in 30 seconds
Time Frame: 12 weeks
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional balance
Time Frame: 12 weeks
Bergs Balance Scale
12 weeks
Walking ability
Time Frame: 12 weeks
walking propulsion indoors for a distance of 10 m at self-selected speed
12 weeks
Everyday activities and function
Time Frame: 12 weeks
Functional Independence Measure (FIM) which comprises 18 items grouped in the following functional domains: bathing, bowel management, toileting, eating, dressing lower body and social interaction. It is scored on a 7-point scale from 1 (dependent) to 7 (independent). 29. Cohen ME & Marino RJ. The tools of disability outcomes research functional status measures. Arch Phys Med Rehabil 2000;81:21-29
12 weeks
Nutritional status
Time Frame: 12 weeks
Mini Nutritional Assessment,
12 weeks
Body composition
Time Frame: 12 weeks
bioelectrical impedance analysis
12 weeks
Blood Chemistry - albumin
Time Frame: 12 weeks
plasma albumin
12 weeks
Blood Chemistry - transthyretin
Time Frame: 12 weeks
plasma transthyretin
12 weeks
Blood Chemistry - CRP
Time Frame: 12 weeks
plasma C-reactive protein (CRP)
12 weeks
Blood Chemistry - IGF-1
Time Frame: 12 weeks
The anabolic mediator plasma insuline-like growth factor-1 (IGF-I)
12 weeks
Blood Chemistry - S-25 vit D
Time Frame: 12 weeks
D-vitamin status will be assessed by S-25 (OH) vitamin D
12 weeks
Blood Chemistry - creatinin
Time Frame: 12 weeks
Plasma creatinin
12 weeks
Blood Chemistry - Cystatin C
Time Frame: 12 weeks
Plasma-Cystatin C
12 weeks
Quality of Life
Time Frame: 12 weeks
EQ-5D, the Euroqool instrument
12 weeks
Healthcare Resource Use - hospitalisations
Time Frame: 12 weeks
hospitalisations
12 weeks
Healthcare Resource Use - length of stay
Time Frame: 12 weeks
length of stay at hospital
12 weeks
Healthcare Resource Use - number of visits
Time Frame: 12 weeks
the number of visits to healthcare professionals (both as outpatients and as a home visit
12 weeks
Healthcare Resource Use - time of staff
Time Frame: 12 weeks
the time of the staff (nursing aides) in the training and implementation of the intervention
12 weeks
Medical incidences - fall
Time Frame: 12 weeks
frequency and incidence of falls
12 weeks
Medical incidences - pressure ulcers
Time Frame: 12 weeks
frequency and incidence of pressure ulcers
12 weeks
Medical incidences - infections
Time Frame: 12 weeks
frequency and incidence of infections
12 weeks
Medical incidences - incontinence
Time Frame: 12 weeks
frequency and incidence of incontinence
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Anne-Marie Bostrom, PhD, Karolinska Institutet

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2016

Primary Completion (Actual)

December 11, 2017

Study Completion (Actual)

December 11, 2017

Study Registration Dates

First Submitted

February 26, 2016

First Submitted That Met QC Criteria

March 2, 2016

First Posted (Estimate)

March 8, 2016

Study Record Updates

Last Update Posted (Actual)

April 26, 2019

Last Update Submitted That Met QC Criteria

April 25, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ISS.FinGrant_Fortimel_2015

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Malnutrition

Clinical Trials on oral protein-rich supplement

Subscribe